StaphAseptic Kills Germs to Prevent MRSA Infection

Grand Rapids, MI (October 30, 2007) — Public concern about Methicillin Resistant Staphylococcus aureus, otherwise known as MRSA staph infections, is at an all-time high after several deaths were recently linked to the disease. StaphAseptic first aid gel, a wound care treatment that kills over 99.9% of MRSA germs, joins the skin care product lineup distributed by Grabber to the sporting goods industry.

Football players, wrestlers and other sports enthusiasts should be aware of the growing problem of antibiotic resistant germs that spread easily from person to person, due to frequent contact and sharing items like towels or other equipment. According to the Centers for Disease Control and Prevention, MRSA appeared in the 1970s as a healthcare-associated infection but over the next two decades emerged as a cause of infection in the public community, particularly among sports participants. Outbreaks are often first detected as clusters of abscesses on the skin or what appear to be “spider bite” wounds.

While commonly used topical antibiotics—including popular triple antibiotic creams and gels—have not been shown to prevent MRSA infections, StaphAseptic kills almost all such germs. Proper care should always be taken with any active wound, including cleaning, treatment, covering and consulting a physician.